Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial

Quique Bassat, Modest Mulenga, Halidou Tinto et al. · 2009

Read Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial by Quique Bassat, Modest Mulenga, Halidou Tinto et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0007871.txt.

Description

Quique Bassat and co-authors published a trial in PLOS ONE in 2009. It compares two combination therapies for malaria in African children. Artemisinin combination therapies were the preferred treatment for uncomplicated malaria. One fixed-dose option, dihydroartemisinin-piperaquine, looked promising but had limited data in African children.

The randomised trial tested it against artemether-lumefantrine, a standard rival. The design was a non-inferiority trial, asking whether the new pairing is no worse. Both safety and efficacy were measured in the children. Solid trial data like this shapes malaria treatment policy across Africa. It also helps clinics choose which drug to stock first.

Catalog record

CREATORQuique Bassat, Modest Mulenga, Halidou Tinto et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007871

Browse the full library · About the Tower of Babel